Conclusion GLP-1 medications work by slowing digestion and reducing appetite, but these mechanisms can lead to gastrointestinal (GI) side effects for as many as 40% of patients
Fatigue should be discussed with a doctor when it is persistent, severe, or associated with dizziness, weakness, fainting, low blood sugar symptoms, inability to exercise, difficulty eating enough, or rapid decline in function
Neither the NAD+ cohort nor the placebo (saline) cohort experienced any negative side effects throughout the 6 hour infusion (10) At 8 hours following the start of the NAD+ infusion, it was shown that the NAD+ group had significant declines in the liver function enzymes gamma glutamyl transferase, lactate dehydrogenase, and aspartate aminotransferase as well as a large increase in plasma bilirubin (10)
Monoclonal antibodies (Becton Dickinson Biosciences, Franklin Lakes, NJ, United States) that were coupled to different fluorophores were used for each cell subset (anti-CD4-PE and anti-CD8-Alexa488)